The discrepancy in the extent of neutrophil response between the CARD9-deficient mice and in patients could be attributed to differences in the timing of sampling, as onset of infection is precisely known in mice, allowing for early sampling, while patient samples are by definition collected later, during symptomatic stages of the disease. The gene discussed is CARD9; the disease is infection.